Valuation: Moderna, Inc.

Market Cap 25.28B 430B 21.82B 20.47B 18.65B 35.06B 2,417B 35.55B 240B 94.05B 1,211B 94.91B 92.85B 4,028B P/E 2026 *
-7.38x
P/E 2027 * -12.9x
Enterprise Value 21.63B 368B 18.67B 17.52B 15.96B 30B 2,068B 30.42B 205B 80.48B 1,036B 81.21B 79.45B 3,447B EV / Sales 2026 *
10.3x
EV / Sales 2027 * 9.47x
Free-Float
92.68%
Yield 2026 *
-
Yield 2027 * -
1 day+0.46%
1 week+7.43%
Current month+12.44%
1 month-1.36%
3 months+29.78%
6 months+48.56%
Current year+104.33%
1 week 1,015
Extreme 1015
1,099.99
1 month 932
Extreme 932
1,099.99
Current year 555
Extreme 555
1,451.38
1 year 414
Extreme 414
1,451.38
3 years 414
Extreme 414
2,820
5 years 414
Extreme 414
9,246.09
10 years 254.3
Extreme 254.3
9,913.99
Manager TitleAgeSince
Chief Executive Officer 54 2011-02-28
Director of Finance/CFO 49 2022-09-05
President 50 2024-10-31
Director TitleAgeSince
Chairman 63 2012-01-31
Director/Board Member 54 2011-02-28
Director/Board Member 69 2019-12-10
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%+7.43% - - 25.28B
+0.30%+2.75%+38.86%+1.08% 80.23B
-1.02%-0.51%-2.54%+28.91% 50.64B
+1.46%-3.45%+11.90%+164.29% 46.87B
-1.39%+1.82%-50.22%-50.44% 46.34B
-0.32%+0.58%+50.90%-21.15% 31B
+1.80%+8.94%+130.05%-34.84% 25.28B
+2.78%+2.44%+42.08%+90.79% 24.36B
+1.65%+0.53%-2.21%+190.26% 20.81B
+3.95%+1.02%+67.20%+117.59% 16.08B
Average +0.99%+0.45%+31.78%+54.05% 37.96B
Weighted average by Cap. +0.53%+0.58%+23.84%+39.34%

Financials

2026 *2027 *
Net sales 2.11B 35.86B 1.82B 1.71B 1.55B 2.92B 201B 2.96B 20B 7.84B 101B 7.91B 7.74B 336B 2.43B 41.34B 2.1B 1.97B 1.79B 3.37B 232B 3.42B 23.06B 9.03B 116B 9.12B 8.92B 387B
Net income -3.38B -57.52B -2.92B -2.74B -2.49B -4.69B -323B -4.75B -32.08B -12.57B -162B -12.69B -12.41B -538B -1.92B -32.75B -1.66B -1.56B -1.42B -2.67B -184B -2.71B -18.27B -7.16B -92.16B -7.22B -7.07B -307B
Net Debt -3.65B -62.11B -3.15B -2.96B -2.69B -5.06B -349B -5.13B -34.65B -13.58B -175B -13.7B -13.4B -581B -2.27B -38.66B -1.96B -1.84B -1.68B -3.15B -217B -3.19B -21.57B -8.45B -109B -8.53B -8.34B -362B
Logo Moderna, Inc.
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (96.1%); - revenue from collaboration agreements (1.5%); - revenue from royalties and licensing (1.3%); - revenue from grants (1.1%). At the end of 2024, the group's portfolio comprises 37 products in clinical development, of which 10 in phase I, 18 in phase II and 9 in phase III, 3 products in preclinical development, and 4 products in commercial phase. Net sales are distributed geographically as follows: the United States (55.1%), Europe (18.5%) and other (26.4%).
Employees
4,700
Date Price Change Volume
26-08-17 MX$1,085.00 0.00% 9
26-08-14 MX$1,085.00 +0.46% 147
26-08-13 MX$1,080.00 -0.61% 495
26-08-12 MX$1,086.67 +5.50% 869
26-08-11 MX$1,030.00 +0.88% 220
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
63.32USD
Average target price
50.84USD
Spread / Average Target
-19.71%

Quarterly revenue - Rate of surprise